课题基金 / 基金详情

Equipment and Instrument Infrastructure Improvement for the MMRRC at UC Davis

Equipment and Instrument Infrastructure Improvement for the MMRRC at UC Davis
加州大学戴维斯分校 MMRRC 的设备和仪器基础设施改进
批准号:
10805721
负责人:
KC KENT LLOYD
金额:
$47.83万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-04-01 至 2025-01-31

项目摘要

项目成果

KC KENT LLOYD的其他基金

相似基金

相关文献

中文摘要
翻译
加州大学戴维斯分校MMRRC设备和仪器基础设施改进
英文摘要
Equipment and Instrument Infrastructure Improvement for the MMRRC at UC Davis ABSTRACT & SCOPE OF WORK The Mutant Mouse Resource and Research Center at the University of California, Davis (MMRRC) is pleased to submit this administrative supplement for up to 1 year of support in response to ORIP's participation in PA- 20-272, “Administrative Supplements to Existing NIH Grants and Cooperative Agreements” specifically related to support alterations and renovations (A&R) of facilities and/or purchase of instruments and equipment in support of non-AIDS research. This application proposes the purchase and installation of equipment and instrumentation to ensure and increase the quality, rigor, and capability of husbandry, production, and phenotyping of mutant mouse lines maintained and distributed by the MMRRC. Specifically, this application requests funds to improve operations, serviceability, functionality and capability of our MMRRC facilities by 1) replacing broken and irreparable cryorecovery and analytical instrumentation and to enable off-site storage of the MMRRC germplasm cryoarchive, 2) upgrading existing animal transfer stations to substantially improve the quality of specific pathogen-free (SPF) husbandry for MMRRC mouse strains, and 3) obtaining and incorporating specialized instrumentation and equipment to facilitate new and implement improvements in musculoskeletal, pulmonary, and behavioral phenotyping capabilities that add substantively to research integrity, rigor, and reproducibility. Funding of this project will accomplish 5 things. First, it will significantly improve cryorecovery and IVF efficiency, thus accelerating the availability and facilitating the rapid dissemination of mouse lines to requesting investigators. Second, it will expedite quality control analysis of the reproductive biology of MMRRC mouse strains, adding valuable information to users regarding sperm phenotype and ensuring their recovery from the cryoarchive. Third, it will dramatically improve the quality of husbandry and health care for MMRRC mice and provide allergen containment to protect vivarium staff. Fourth, it will enable the validation and depth of phenotyping that can be conducted on all MMRRC mouse strains, thus directly responding to users' requests for more extensive and comprehensive testing and analysis. Fifth, it will improve rigor, reproducibility, and transparency in production and phenotyping activities, further supporting efforts by the MMRRC to achieve approved vendor status by institutions across the country. Together, these upgrades will significantly enhance our ability to meet the increased expectations of MMRRC clientele for fully comprehensively validated mouse models and optimize production and phenotyping services. Further, because these upgrades are MMRRC-project specific, they are beyond the support provided by the UC Davis campus for basic operations and maintenance. The overall outcome of this supplement will be to exert a sustained and powerful influence on operations of the MMRRC by improving and expanding its capability to more expertly maintain, manage, and characterize genetically-modified mouse strains and meet the needs of the national biomedical research community conducting NIH-funded research. By doing so, this supplement will provide a sustained benefit to the overall research community and have a positive impact on NIH-funded research. The parent peer-reviewed NIH funded grant (U42OD012210) has been competitively renewed (as of January 1, 2020) for 5 years. A budget of $478,325 (total costs) requested for the remaining months of the current grant year (until January 31, 2024) is less than half the annual total direct cost budget of the parent grant. The proposed activities all fall within the scope of the parent award, which includes archiving, phenotyping, and distributing investigator-derived and Center-produced mutant mouse lines.
期刊论文(97)
专著(0)
科研奖励(0)
会议论文
Potential independent action of sigma receptor ligands through inhibition of the Kv2.1 channel.
西格玛受体配体通过抑制 Kv2.1 通道的潜在独立作用
DOI: 10.18632/oncotarget.19581
发表时间: 2017-08-29
期刊: Oncotarget
影响因子: --
作者: [Liu X, Fu Y, Yang H, Mavlyutov T, Li J, McCurdy CR, Guo LW, Pattnaik BR]
通讯作者: Pattnaik BR
DOI: 10.3389/fncel.2018.00173
发表时间: 2018
期刊: Frontiers in cellular neuroscience
影响因子: 5.3
作者: [Noristani HN, They L, Perrin FE]
通讯作者: Perrin FE
DOI: 10.3389/fnmol.2018.00041
发表时间: 2018
期刊: Frontiers in molecular neuroscience
影响因子: 4.8
作者: [Dahlhaus R]
通讯作者: Dahlhaus R
Characterization of multi-cellular dynamics of angiogenesis and vascular remodelling by intravital imaging of the wounded mouse cornea.
通过受伤小鼠角膜的活体成像来表征血管生成和血管重塑的多细胞动力学。
DOI: 10.1038/s41598-018-28770-7
发表时间: 2018
期刊: Scientific reports
影响因子: 4.6
作者: [Wang,Yixin, Jin,Yi, Laviña,Bàrbara, Jakobsson,Lars]
通讯作者: Jakobsson,Lars
70
    Administrative Core
    PDX Core
    The National Center for Metabolic Phenotyping of Mouse Models of Obesity and Diabetes (MPMOD) at UC Davis
    MMPC-Live Consortium Marketing and Outreach
    海外基金